What does innovation mean to Bracco? At ECR2024, Fabio Tedoldi, Head of Global Research & Development at Bracco Imaging, engaged in a conversation on Innovation with Mélisande Rouger of Diagnostic Imaging Europe (DIE), the leading pan-European resource for medical imaging news, analysis, and trends. 

Bracco Suisse and Verasonics: a new strategic partnership The collaboration focuses on combining Verasonics' Vantage®️ NXT Research Ultrasound Systems with Bracco's contrast agents to explore improved imaging performance in various research applications.

Blue Earth Diagnostics appoints Marco Campione as Chief Executive Officer Mr. Campione brings more than 25 years global experience in successful development and commercialization of diagnostic imaging agents and radiopharmaceuticals.

Storie dal nostro Bilancio di Sostenibilità 2022 Condurre il business in modo etico, sostenere l’innovazione continua, promuovere il rapporto di collaborazione con gli operatori sanitari e implementare politiche e azioni per la sostenibilità, sono tutti modi in cui concretizziamo il nostro impegno. Abbiamo scelto di raccontare la storia di Bracco attraverso le voci delle nostre persone.

Bracco Imaging ha ottenuto la Medaglia d'Oro di EcoVadis per il secondo anno consecutivo Nel 2024, Bracco è stata riconfermata nel 5% delle migliori 100.000 aziende globali certificate da EcoVadis, incrementando il punteggio da 73 a 79 su 100.

EFSUMB CEUS course 2024 3rd EFSUMB CEUS course 2024 will be taking place on Nov 9/10 in parallel to the Euroson congress in Naples.

Bracco Imaging and Arrayus Technologies: a new strategic partnership Bracco Imaging and Arrayus Technologies have partnered to improve drug delivery for pancreatic cancer using focused ultrasound and microbubble technology.

AI Pills in Medical Writing This webinar series, in collaboration with Springer Healthcare Italia, a global leader in healthcare education and communication, is designed to provide radiologists with practical insights into the use of innovative digital tools and technologies to improve the effectiveness of medical writing.

Gadopiclenol riceve il JFR 2024 Innovation Award Bracco Imaging è lieta di annunciare che Gadopiclenol (commercializzato come Vueway® da Bracco) è stato insignito del JFR* 2024 Innovation Award nella categoria Favorite della giuria.

Bracco Diagnostics and Subtle Medical Announce FDA Clearance of AiMIFY™ Software Bracco Diagnostics Inc. and Subtle Medical, Inc. are thrilled to announce that their collaborative AI-powered software, AiMIFYTM, has received FDA clearance as a Class II software as a medical device (SaMD) for magnetic resonance imaging (MRI) of the brain.